VIVANZAPharmaceuticals
Vivanza Biosciences Ltd — Quarterly Results & Earnings
₹1.76
+0.00%
Profit Growth YoY2700.00%Latest quarter
Sales Growth YoY1745.33%Latest quarter
Sales CAGR 5Y-5.02%5 year compound
Profit CAGR 5YN/A5 year compound
📋
Quarterly Performance
YoY Profit Growth+2700.00%
🔥 Exceptional growth
YoY Sales Growth+1745.33%
🔥 Exceptional growth
OPM 5Y Average
1.94%Operating profit margin
EPS Growth 5Y
N/AInterest Coverage
0.07Higher = safer debt servicing
ROE
-15.58%ROCE
-2.77%💡
Growth Analysis
Vivanza Biosciences Ltd reported YoY profit growth of 2700.00% and revenue growth of 1745.33% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at -5.02% and profits at N/A annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Vivanza Biosciences Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.